Zenabis announces that Health Canada has issued an amendment to its Producer’s License. Zenabis is now eligible to sell clones to other licensed producers under current Access to Cannabis for Medical Purposes Regulations (ACMPR). The amended license also opens the door for the company to meet national demand for high-quality cannabis.
The amended sales license was issued for Zenabis’ 380,000 square foot facility in Atholville, New Brunswick, and is effective from April 13, 2018 through January 19, 2021. Zenabis received its cultivation license for Atholville in August 2017, and has since been growing pharmaceutical-grade cannabis plants and preparing for its release of cannabis strains.
“Obtaining our license to sell cannabis plants is a significant milestone for Zenabis and an incredible opportunity for innovation,” stated Kevin Coft, CEO of Zenabis. “We take pride in the quality and craftsmanship of our cannabis plants and with this amended license can now support the Canadian cannabis community.”
For more information:
Zenabis
info@zenabis.com
www.zenabis.com
Sign up for our daily Newsletter and stay up to date with all the latest news!
Subscribe I am already a subscriber